Twenty years of progress with parathyroid hormone (PTH): from specialized and "difficult" measurement to common laboratory parameter and treatment option in osteoporosis.
Blind
Eberhard
E
European Medicines Agency (EMEA), London, United Kingdom. eberhard.blind@emea.europa.eu
D000595:Amino Acid Sequence; D015519:Bone Density; D002118:Calcium / Q000378:metabolism; D019963:Clinical Chemistry Tests; D006801:Humans; D006934:Hypercalcemia / Q000175:diagnosis*; D006961:Hyperparathyroidism / Q000175:diagnosis*; D006996:Hypocalcemia / Q000175:diagnosis*; D010024:Osteoporosis / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000097:blood* / Q000627:therapeutic use*; D011863:Radioimmunoassay
D010281:Parathyroid Hormone; D002118:Calcium